Progyny, Inc. (PGNY)
NASDAQ:PGNY
PGNY Stock Chart & Stats
$16.30
$0.60(3.43%)
At close: 4:00 PM EST
$16.30
$0.60(3.43%)
Day’s Range― - ―
52-Week Range$16.10 - $28.75
Previous CloseN/A
Volume466.97K
Average Volume (3M)1.44M
Market Cap
$1.34B
Enterprise Value$1.25B
Total Cash (Recent Filing)$310.10M
Total Debt (Recent Filing)$27.73M
Price to Earnings (P/E)37.4
Beta0.49
Next Earnings
May 07, 2026EPS Estimate
0.26Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.14
Shares Outstanding81,902,230
10 Day Avg. Volume1,014,727
30 Day Avg. Volume1,442,778
Financial Highlights & Ratios
PEG Ratio2.45
Price to Book (P/B)4.24
Price to Sales (P/S)1.70
P/FCF Ratio11.41
Enterprise Value/Market Cap0.94
Enterprise Value/Revenue0.97
Enterprise Value/Gross Profit4.11
Enterprise Value/Ebitda12.76
Forecast
1Y Price Target
$27.22Price Target Upside66.99% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
EPS Forecast (FY)1.17
Revenue Forecast (FY)$1.38B
Bulls Say, Bears Say
Bulls Say
Client Retention And Account ExpansionExtremely high client retention and a sizable portion of customers expanding benefits support stable recurring revenue and create upside as existing accounts deepen use of services.
Margins And Cash Flow StrengthExpanded gross margins and strong operating cash flow indicate improving unit economics and provide flexibility for further investment or shareholder returns.
Product Offering And Market ExpansionProgyny Select's lower-cost design for smaller employers could broaden the addressable market and drive new sales by appealing to employers that previously found services unaffordable.
Bears Say
Covered Lives And Demand SensitivityReported declines in covered lives raise concern that higher unemployment and reduced benefit enrollment could lower utilization and future sales, pressuring revenue growth.
Guidance Miss And Investor SentimentSofter-than-expected forward guidance alongside limited identifiable near-term catalysts has increased investor caution and could sustain downward pressure on the stock until clear growth drivers reappear.
Large Customer Concentration RiskLoss of a single large customer materially reduced revenue and weakens near-term guidance, highlighting customer concentration risk and potential volatility in reported growth.
Progyny News
PGNY FAQ
What was Progyny, Inc.’s price range in the past 12 months?
Progyny, Inc. lowest stock price was $16.10 and its highest was $28.75 in the past 12 months.
What is Progyny, Inc.’s market cap?
Progyny, Inc.’s market cap is $1.34B.
When is Progyny, Inc.’s upcoming earnings report date?
Progyny, Inc.’s upcoming earnings report date is May 07, 2026 which is in 25 days.
How were Progyny, Inc.’s earnings last quarter?
Progyny, Inc. released its earnings results on Feb 26, 2026. The company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.147 by -$0.007.
Is Progyny, Inc. overvalued?
According to Wall Street analysts Progyny, Inc.’s price is currently Undervalued.
Does Progyny, Inc. pay dividends?
Progyny, Inc. does not currently pay dividends.
What is Progyny, Inc.’s EPS estimate?
Progyny, Inc.’s EPS estimate is 0.26.
How many shares outstanding does Progyny, Inc. have?
Progyny, Inc. has 81,902,230 shares outstanding.
What happened to Progyny, Inc.’s price movement after its last earnings report?
Progyny, Inc. reported an EPS of $0.14 in its last earnings report, missing expectations of $0.147. Following the earnings report the stock price went down -20.494%.
Which hedge fund is a major shareholder of Progyny, Inc.?
Currently, no hedge funds are holding shares in PGNY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Progyny Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$27.22 (66.99% Upside)
$27.22 (66.99% Upside)
Blogger Sentiment
Bullish
PGNY Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 493.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 2.9%
Last 30 Days ▲ 1.2%
Last 30 Days ▲ 1.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-26.77%
12-Months-Change
Fundamentals
Return on Equity
11.37%
Trailing 12-Months
Asset Growth
22.51%
Trailing 12-Months
Company Description
Progyny, Inc.
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
PGNY Company Deck
PGNY Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed materially positive operational and financial momentum: record revenue, adjusted EBITDA and operating cash flow; margin expansion and healthy member engagement; strong balance sheet and active share repurchases. The company is investing in product expansion (Progyny Select, Rx and maternal health services) while managing risk via conservative guidance assumptions. Key near-term negatives include an administrative reduction in reported covered lives (~400k), a one-time $7.7 million stock-comp acceleration, elevated CapEx in 2025, and guidance conservatism to account for utilization variability and regulatory uncertainty in pharmacy rebates. Overall, the positives (record results, cash generation, margin gains, client retention and product runway) outweigh the transitory and manageable lowlights.View all PGNY earnings summariesPGNY Stock 12 Month Forecast
Average Price Target
$27.22
▲(66.99% Upside)
Technical Analysis
Ownership Overview
2.69% Insiders
33.68% Mutual Funds
17.75% Other Institutional Investors
17.78% Public Companies and Individual Investors